Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexchlorpheniramine/Pseudoephedrine/Guaifenesin for Allergic Rhinitis and Viral Infection
NCT01085721Phase 3Unknown
- Sponsor
- Mantecorp Farmasa
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial in allergic rhinitis (AR) and viral upper respiratory tract infection comparing Dexchlorpheniramine + Pseudoephedrine + Guaifenesin with Dexchlorpheniramine (2 arms). Primary endpoint: Visual Analogic Scale for Symptoms at 5 days. Status: unknown.
02
Drugs
dexchlorpheniraminepseudoephedrineguaifenesin
03
Conditions
allergic rhinitis (AR)viral upper respiratory tract infection
Beyond the preview
Go deeper on NCT01085721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01085721.